BOTOX
NDC 0023-1145 · Allergan, Inc.
Packages
0023-1145-01 — 1 VIAL in 1 CARTON (0023-1145-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
0023-1145-02 — 1 VIAL in 1 CARTON (0023-1145-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
Billed under HCPCS
J0585 — Injection, onabotulinumtoxina, 1 unit Medicare Part B payment limit (ASP + 6%): $6.51
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0023-3919 — onabotulinumtoxinA, 0023-3921 — onabotulinumtoxinA, 0023-9232 — onabotulinumtoxinA, 0259-1605 — incobotulinumtoxinA, 0259-1610 — incobotulinumtoxinA, 0259-1620 — incobotulinumtoxinA, 0259-4110 — incobotulinumtoxinA, 0259-4150 — incobotulinumtoxinA, 0299-5962 — Botulinum Toxin Type A, 15054-0500 — Botulinum Toxin Type A, 15054-0530 — Botulinum Toxin Type A, 46783-160 — incobotulinumtoxinA, 46783-161 — incobotulinumtoxinA, 46783-165 — incobotulinumtoxinA, 72301-595 — Prabotulinum Toxin Type A, 72960-112 — botulinum toxin type A, 85766-155 — onabotulinumtoxinA
Poisoning, adverse-effect and underdosing codes for this drug
The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.
T48.291 — Poisoning by other drugs acting on muscles, accidental (unintentional), T48.292 — Poisoning by other drugs acting on muscles, intentional self-harm, T48.293 — Poisoning by other drugs acting on muscles, assault, T48.294 — Poisoning by other drugs acting on muscles, undetermined, T48.295 — Adverse effect of other drugs acting on muscles, T48.296 — Underdosing of other drugs acting on muscles